Friedrich & ClementBETA

How to bid in this country: portals, deadlines, thresholds →

Open house pharmaceutical discount agreements for the active ingredient prednisone, ATC H02AB07

Open house Arzneimittelrabattverträge zum Wirkstoff Prednison, ATC H02AB07 — original title

DEGermany · Eisenberg
Open-house procedure. Any company meeting the conditions can join the contract — there is no competition for an award. The date shown is the end of the joining phase or of the contract term.

Your path to submission

  1. Deadline: 28 February 2027 at 23:59 — 120 days left.
  2. You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
  3. Offer and evidence in: German.
  4. Collect your evidence — use the eligibility analysis on this page: it lists the requirements and, for known certificates, how to get them.
Compiled automatically from notice and documents — no guarantee; the procedure's wording is binding.

What the buyer is looking for

The AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse offers discount contracts with the above-mentioned active ingredient to all interested pharmaceutical companies without a selection decision. The contracts are concluded within the framework of an "open house model". The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are desired by the AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. In the Open House model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniform - individual negotiations are not conducted. The contract duration is a maximum of 24 months, the earliest contract start date is 01.05.2025. All contracts end no later than 24 months after the date of the earliest start of the contract, regardless of the date of the respective conclusion of the contract. An…

Show full description

… accession or conclusion of a contract can take place within the 24-month period at the first of each month. There is a right of termination 6 weeks at the end of each month in accordance with the provisions of the contract. Further information on termination options can be found in the contract documents. The AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse reserves the right to replace the non-exclusive Open House discount contracts with exclusive discount contracts during the contract period within the framework of Europe-wide tender procedures. With the entry into force of advertised, exclusive discount contracts, the Open House contracts are terminated in accordance with the contractual regulation, i.e. the Open House contracts end automatically. Interested pharmaceutical companies can request the participation documents as well as the contract documents from the mentioned contact address. Contracts for the above-mentioned active substance will be concluded for the first time with effect from 01.05.2025. Interested parties who would like to become contractual partners on this date must submit the contractual documents to the AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse by 31.03.2025. Access to the AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse is essential. Note: The first award in this procedure shall be made no earlier than 10 calendar days after the publication of this EU notice in the Official Journal. Later contracts can be concluded during the 24-month maximum term at the first of each month. In the case of interested parties who wish to become contractual partners on these subsequent dates, the receipt of the contract documents, including the annexes, must be submitted no later than the end of the month preceding the previous month of the desired start of the contract (e.g. receipt 30.04. at the start of the contract 01.06.). The exact deadlines for receipt will be announced with the contract documents. This publication does not constitute the award of a public contract within the meaning of the Public Procurement Coordination Directive 2014/24/EU of the European Parliament and of the Council or of public procurement law. Publication in the Supplement to the Official Journal of the European Union shall be carried out in order to ensure as much transparency as possible as regards the intended conclusion of contracts. In the absence of a publication form, the contract notice shall be used. The resulting conceptual requirements, such as the procedural designation "open procedure", are solely due to the use of this notice form and the publication platform. A further meaning, in particular a submission to public procurement regulations, insofar as they are not obligatory for legal reasons, is not associated with this.

Machine translation (EU eTranslation) — official wording via the PDF link.

Contract

TypeSupplies
Estimated valuevalue not published
Published13 Mar 2025
ProcedureOpen procedure
Contract period1 May 2025 → 30 Apr 2027
Place of performanceEisenberg

Type of service

33 · Medical equipment & pharma
CPV 33600000

Clement What the numbers say about this buyer

  • In this sector the buyer awards roughly every month (847 awards, most recently February 2026) — by that rhythm the next award was due around March 2026. The last award went to Novo Nordisk Pharma GmbH.n = 847
  • 37% of the bids received came from other countries (27 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 27
  • 90% of the bids received came from small and medium-sized enterprises (27 procedures with a bid mix). Sector: 38%.n = 27
  • The award came in at a median 56% of the estimated value (14 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 87%.n = 14
  • 68% of this buyer's awards went to companies that had already won here before (987 awards since 2018, spread over 320 companies). 32% went to new names.n = 987 awards since 2018

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 25/10/2026.

Clement
In this buyer's last 890 comparable contracts (same sector), usually only a single offer came in — a solid bid has real chances.
References and certificates from your home country count fully across the EU — that is what European procurement law is for.

What you must prove — eligibility criteria

›
other
Im Rahmen dieses Vertrages dürfen grundsätzlich nur zugelassene und in Deutschland verkehrsfähige Arzneimittel abgegeben werden. Sofern ein Arzneimittel in der Lauer-Taxe als verkehrsfähig gelistet ist, gilt dieser Umstand als nachgewiesen. Falls ein Arzneimit… read in fullcollapse
Im Rahmen dieses Vertrages dürfen grundsätzlich nur zugelassene und in Deutschland verkehrsfähige Arzneimittel abgegeben werden. Sofern ein Arzneimittel in der Lauer-Taxe als verkehrsfähig gelistet ist, gilt dieser Umstand als nachgewiesen. Falls ein Arzneimittel, das Bestandteil dieses Vertrages werden soll, zu dem Zeitpunkt, zu dem der pharmazeutische Unternehmer die unterzeichneten Vertragsunterlagen an die AOK übersendet, noch nicht in der Lauer-Taxe gelistet ist oder der Eintrag noch nicht angezeigt wird, gelten die nachfolgenden Regelungen. Maßgeblich ist der Zeitpunkt der Absendung der Unterlagen, bei vorheriger elektronischer Übermittlung der Unterlagen gilt der Zeitpunkt der elektronischen Übermittlung als maßgeblich. In den vorgenannten Fällen hat der Vertragspartner der AOK bereits bei Übermittlung der Unterlagen einen Auszug aus dem Öffentlichen Teil der AMIce-Datenbank, des Arzneimittelinformationssystems des Deutschen Instituts für medizinische Dokumentation und Information (DIMDI), für die vertragsgegenständlichen Arzneimittel, die der Vertragspartner zum Zeitpunkt des Vertragsschlusses in Vertrieb hat, zur Verfügung zu stellen. Dabei müssen sich aus den Auszügen die folgenden Informationen zur aktuellen Zulassungssituation aller vertragsgegenständlichen Arzneimittel ergeben: a. Name/Bezeichnung des Arzneimittels, b. Name des Inhabers der Zulassung (alternativ: Name des aus sonstigem Grund zum Inverkehrbringen des Arzneimittels berechtigten pharmazeutischen Unternehmers im Sinne des § 4 Abs. 18 Satz 2 AMG und Angabe des Grundes dieser Berechtigung), wobei die Stellung gerade des Bieters als pharmazeutischer Unternehmer im Hinblick auf die von ihm angebotenen Arzneimittel und der Grund dafür nachgewiesen werden müssen, c. Darreichungsform, d. Wirkstoff, e. Angabe zur Verkehrsfähigkeit. Soweit bei einem Arzneimittel die aktuelle zulassungsrechtliche Situation im Hinblick auf die gemäß Buchstaben a bis e erforderlichen Informationen von dem im öffentlichen Teil der AMIce-Datenbank bei Vertragsschluss verfügbaren letzten Stand abweicht und soweit weder der kostenlos noch der kostenpflichtig erhältliche Auszug aus dem Öffentlichen Teil der AMIce-Datenbank alle gemäß Buchstaben a bis e erforderlichen Informationen vollständig ausweist, hat der Vertragspartner den aktuellen Stand und/oder die fehlenden Informationen durch Vorlage geeigneter ergänzender Nachweise (z.B. Kopie des Zulassungsbescheides, Kopien von Änderungsanzeigen, eidesstattliche Versicherung etc.) zusammen mit dem Auszug aus dem Öffentlichen Teil der AMIce-Datenbank glaubhaft zu machen.
Requirement texts are quoted in the notice's original language — only the official wording is binding.

Tender documents — direct download

⤓
Annex 1
Specifications and annexes at the buyer — usually viewable without registration
⤓
Administrative conditions
The full notice, official wording

Who has won at this buyer so far

Across all contract types of this buyer — not just this sector. A city buys software and fire engines through the same purchasing office.

CompanyAwardsPeriod
axicorp Pharma B.V. · EC Den Haag322017–2022
Aliud Pharma GmbH · Laichingen282017–2023
Abacus Medicine A/S · Kopenhagen272018–2023
kohlpharma GmbH · Merzig262017–2023
EurimPharm Arzneimittel GmbH · Saaldorf-Surheim252019–2023
From the recorded awards · regular winners know this buyer's requirements — that is your competition.

How often this buyer tenders this kind of work

284
2019
289
2020
316
2021
327
2022
412
2023
412
2024
460
2025
247
2026
2,747 procedures in this category since 2019. Public procurement repeats itself — those who know the rhythm prepare instead of reacting.

Contracting authority contact

·
Deadline — Sunday, 28 February 2027 at 23:59

Tactics

When this buyer has awarded in this sector, there was usually a single bid in the end. A solid bid has a real chance here. (Based on 890 completed awards — not a statement about this procedure.)

This procedure allows 718 days between publication and deadline — typical in this country is 32 (median of 20,071 procedures). Much more generous than usual — time for a thorough bid rather than a quick one.

Foreign bidders

In Germany · Medical equipment & pharma, 270 contracts went to foreign companies over the last 3 years (of 22,355 recorded awards) — mostly from Austria, Netherlands, France.

Submission language: German.

Measured from linked award data; foreign winners bidding through a local subsidiary count as domestic — the true share is higher.

How to bid

Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
This procedure is published on 2 portals
Bids are submitted on Vergabemarktplatz (cosinex) — TED carries the same notice, usually with the more detailed specification. Read both.
TEDNoticeVergabemarktplatz (cosinex)Submission portal
Put together the evidence — in German
The criterion on the left, plus your price.
Submit via TED — Tenders Electronic Daily before the deadline
Electronic submission — allow time for the portal registration the first time.
To the procurement portal (submission) →Official notice on TED →
We pull data from millions of notices. If the link here does not work, report it — we will find the right one.

Don't miss the next one

Friedrich finds tenders like this for you — every morning at 7:30, each one checked by Claude (Anthropic) for fit, and he learns from your feedback what your company really does.

Register now